Agenus (AGEN) Gross Profit (QoQ) (2010 - 2026)
Agenus (AGEN) Gross Profit (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,132.22 Bn | 67,131.94 Bn | - |
| 2 | Nanobiotix | 1,910.87 Bn | 1,910.81 Bn | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - |
| 4 | BeOne Medicines | 471.60 Bn | 466.80 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.71 Bn | 114.46 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.83 Bn | 61.07 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.74 Bn | 62.74 Bn | - |
| 8 | Argenx Se | 55.83 Bn | 50.65 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.33 Bn | 34.32 Bn | 959.66 Mn |
| 10 | Agenus | 232.20 Mn | 197.20 Mn | 33.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 214.17% |
| Dec 31, 2025 | -63.71% |
| Sep 30, 2025 | 16.29% |
| Jun 30, 2025 | 6.35% |
| Mar 31, 2025 | 2,036.00% |
| Dec 31, 2024 | -104.95% |
| Sep 30, 2024 | 6.72% |
| Jun 30, 2024 | -16.14% |
| Mar 31, 2024 | -43.01% |
| Dec 31, 2023 | 103.86% |
| Sep 30, 2023 | -4.12% |
| Jun 30, 2023 | 21.52% |
| Mar 31, 2023 | 139.61% |
| Dec 31, 2022 | -331.62% |
| Sep 30, 2022 | 18.84% |
| Jun 30, 2022 | -25.58% |
| Mar 31, 2022 | 31.05% |
| Dec 31, 2021 | -92.31% |
| Sep 30, 2021 | 2,405.58% |
| Jun 30, 2021 | -5.19% |